跳至主要内容
临床试验/NCT00925717
NCT00925717已完成不适用

of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

AstraZeneca1 个研究点 分布在 1 个国家目标入组 4,045 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
4,045
试验地点
1
主要终点
Investigate LDL-C goal achievement rate according to ADA recommendation

研究概览

简要总结

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who was diagnosed as diabetes
  • Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
  • Clinic visit in the past 6 months more than once

排除标准

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

结局指标

主要结局

Investigate LDL-C goal achievement rate according to ADA recommendation

时间窗: Within the last 6 months from the date of data entry.

次要结局

  • Investigate reduction of 10-year risk for CHD by using UKPDS risk engine(Within the last 6 months from the date of data entry.)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验